Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Fetal Tissue, Stem Cells & Bioethics

No Run on this Bank

It would seem that the California Institute for Regenerative Medicine (CIRM) is not alone as it increasingly moves away from human embryonic stem cell research (hESCR) and towards adult and other non-embryonic avenues of stem cell research.

 

As a recent Lozier Institute study reported, over the years since it was founded to provide financial support for hESCR, CIRM has instead been awarding more and more grants to adult stem cell research.  CIRM’s current strategic plan has as its goal moving projects as quickly as possible to the clinical trial phase, and its pattern of awarding more and more grants to adult stem cell research would indicate that hESCR is falling far short of achieving this goal.

 

 

Enter the University of Massachusetts Stem Cell Bank.

 

 

Or, rather, exit the University of Massachusetts Stem Cell Bank.

 

 

According to news reports, the stem cell bank will run out of money at the end of the year and, when it does, state officials and officials at the University of Massachusetts have agreed to just let it close.

 

 

This was not how things were supposed to turn out.

 

 

As was the case with CIRM, the University of Massachusetts Stem Cell Bank was conceived as push-back against President Bush’s policy of limited federal funding for hESCR.

 

 

“Originally, the bank was seen as a repository for embryonic stem cell lines that were being created but were not eligible for federal funding under Bush-era restrictions,” according to the Boston Globe.

 

 

When it first opened, the bank was “absolutely state of the art,” said Susan Windham-Bannister, president of the Massachusetts Life Sciences Center.  Such a bank housing hESC lines was to be “a marquee piece of Governor Deval Patrick’s effort to bolster the life sciences industry” in Massachusetts.  Towards that end, the state provided just under $8 million to launch the project.

 

 

Yet today, “the bank receives one to two requests a week,” Terence Flotte, dean of University of Massachusetts Medical School, told the Globe.  The most reasonable explanation for this unanticipated development would seem to be that scientists hoping to turn research into cures are losing interest in working with hESCs.

 

 

Or, as the Globe succinctly put it, the bank has “become obsolete.”

 

 

Taken together with CIRM’s favoring of adult/non-embryonic stem cell research, the University of Massachusetts Stem Cell Bank’s closure provides yet more evidence that the therapeutic promise of hESCs – so hyped in the past — is becoming obsolete as well.

 

Gene Tarne is a Senior Analyst at the Charlotte Lozier Institute.

Latest Posts

December 10, 2024 A Defense of New Jersey Pregnancy Centers: Responding to Planned Parenthood Misinformation November 27, 2024 Abortion Reporting: Massachusetts (2023) November 27, 2024 Abortion Reporting: Maine (2023)

You Might Also Be Interested In

The Treatment of Human Embryos Created through IVF: The U.S. and 15 Selected Countries’ Regulations

November 22, 2024
Please login to bookmarkClose

IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

November 13, 2024
Please login to bookmarkClose

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

April 22, 2024
Please login to bookmarkClose

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image